Here at the Janssen Health Policy Centre
our mission is to raise awareness on issues impacting healthcare policy, build
consensus through dialogue, and shape recommendations for future policies

News archive


Among the many things global political leaders have to discuss there is also an extensive agenda on global health issues. The G20, the G7 and others will increasingly be called upon to support the United Nations to address key health challenges.

10 May 2017 Find out more

Learn how investing in better health will benefit us as individuals. This is our contribution to the OECD Observer of 23 February 2017. Janssen is a keen supporter of engagement with all stakeholders in healthcare so that we may shape an even better future for public health.

23 February 2017 Find out more

While innovation is central for the quality of healthcare and improving health outcomes, it is also a source of increasing costs for governments. Confronted by fiscal pressures, governments have made efforts to restrict access to innovative treatments. While such policies are understandable, they are not necessarily supportive of the ambition to control the cost burden of a disease. This paper reviews economic analyses of the cost burden of cancer, and blood cancers in particular, and the effects that innovative treatments have on other sources of costs in the healthcare system or the economy as a whole. Janssen recently sponsored the European Centre for International Political Economy (ECIPE) summit.

14 February 2017 Find out more

High levels of obesity in the Middle East region are the result of a complex combination of interconnected environmental, cultural and biological causes. Policy makers are yet to implement impactful measures to accelerate access to care for obese and metabolic patients. In the meanwhile, obesity is a major economic burden on countries in the region. This is in part due to the link of obesity with associated conditions, such as diabetes, hypertension and cardiovascular problems. According to the International Diabetes Federation (IDF), spending on diabetes care in the Middle East and North Africa (MENA) region, as a percentage of total health expenditures, is already the highest globally. A widespread public perception in the region is that obesity is a symptom of diabetes or hypertension, rather than a disease in itself. Experts say that this perception ultimately makes it more challenging to care for patients, for example highlighted by the fact that insurance frequently won’t cover interventions in the region. Dr. Nadia Ahmed, Obesity Medicine Specialist, states that “the underlying biology is so complex that you have many sub-types of obesity and need many different underlying treatment tracks.” She recommends to have a range of treatments available and accessible as well as providers who are skilled and equipped at applying these treatments with the right healthcare infrastructure that supports assessment and treatment of obesity in that manner. Experts conclude that governments must make sure that rudimentary preventive programs, including education in schools, are in place and include families. For those who are already obese, experts recommend better training of professionals with expertise in the complexities of obesity, particularly the creation of multidisciplinary teams to treat patients, with a core team including specialists in obesity medicine and management, dieticians and even specialist psychologists.    

31 October 2016 Find out more

Report archive